- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
Daiichi Sankyo Company
Market Cap: JP¥6.7t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥3,598.00
7D
10.4%
1Y
-39.1%
Takeda Pharmaceutical
Market Cap: JP¥6.9t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,341.00
7D
-0.8%
1Y
2.6%